bioRxiv preprint doi: https://doi.org/10.1101/2020.08.14.248864; this version posted August 14, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The origins and consequences of UPF1 variants in pancreatic adenosquamous carcinoma Jacob T. Polaski1,2, Dylan B. Udy1,2,3, Luisa F. Escobar-Hoyos4,5,6, Gokce Askan4, Steven D. Leach4,5,7,8, Andrea Ventura9, Ram Kannan9,†, and Robert K. Bradley1,2,† 1Computational Biology Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA 2Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA 3Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, 98195, USA 4David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA 5Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA 6Department of Pathology, Stony Brook University, New York, New York 11794, USA 7Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA 8Dartmouth Norris Cotton Cancer Center, Lebanon, New Hampshire 03766, USA 9Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065 †Correspondence:
[email protected],
[email protected] Keywords: UPF1, pancreatic adenosquamous carcinoma, cancer genomics bioRxiv preprint doi: https://doi.org/10.1101/2020.08.14.248864; this version posted August 14, 2020.